Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

IL-10 mediates Vasogen's immune modulation therapies

May 24, 2000

Selective RXR agonists designed at Allergan particularly useful for skin-related diseases

May 19, 2000

Ligand releases new data confirming Ontak's effectiveness in patients with severe psoriasis

May 15, 2000

Eisai investigates selective RARalpha agonists for dermatologic, immunologic disorders

May 11, 2000

FDA advisory panel recommends approval of Apligraf for diabetic foot ulcers

May 10, 2000

P&G research team focuses on new treatments for hair loss

May 8, 2000

New heterocyclic compounds from Procter & Gamble particularly useful for alopecia

May 5, 2000

Transgenic antibody production agreement signed by Genzyme Transgenics and Abgenix

May 5, 2000

Gliatech submits ADCON-P preclinical module to FDA

May 4, 2000

Dapsone topical gel progresses through the pipeline for acne and itch

April 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...